Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137761 · ClinicalTrials.gov registry record · Phase 2
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
A Phase 2 study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00137761: Completed Phase 2 study, sponsored by Dana-Farber Cancer Institute.
NCT00137761 is a Phase 2 study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 32 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00137761, a Phase 2 study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what activity the combination of docetaxel and Iressa have against metastatic pancreatic cancer.
Interventions
- DRUG Docetaxel
- DRUG ZD 1839
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2004-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
What the finished NCT00137761 record still lists
NCT00137761 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which Docetaxel is the first listed.
NCT00137761 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00137761 about?
NCT00137761 is a clinical study titled "Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer". The purpose of this study is to find out what activity the combination of docetaxel and Iressa have against metastatic pancreatic cancer.
What is the current status of trial NCT00137761?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2004-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00137761?
The interventions under investigation include: Docetaxel (DRUG), ZD 1839 (DRUG).
Who is sponsoring clinical trial NCT00137761?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00137761's enrollment target sits among peer trials
32 1563rd of 2000 higher than 423 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia